Starpharma Revenue
What is the Revenue of Starpharma?
The Revenue of Starpharma Holdings Limited is AUD$9.752M
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on ASX compared to Starpharma
What does Starpharma do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Companies with revenue similar to Starpharma
- Nuchev has Revenue of AUD$9.724M
- The Mandhana Retail Ventures has Revenue of ₨9.731M
- InvestSMART has Revenue of AUD$9.740M
- GLG Life Tech has Revenue of CAD$9.740M
- Inventiva SA has Revenue of €9.745M
- Inventiva S.A has Revenue of €9.745M
- Starpharma has Revenue of AUD$9.752M
- Entreprendre S.A has Revenue of €9.760M
- EQ has Revenue of CAD$9.760M
- Esports Entertainment has Revenue of $9.770M
- Ventus VCT Plc has Revenue of £9.797M
- Ventus VCT D has Revenue of $9.797M
- Ventus VCT C has Revenue of $9.797M